Korsana Biosciences, Inc. (KRSA)
32.83
-2.16
(-6.17%)
USD |
NASDAQ |
Sep 21, 16:00
33.09
+0.26
(+0.79%)
After-Hours: 20:00
Korsana Biosciences Total Liabilities (Quarterly) : 1.843M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.843M |
| March 31, 2026 | 1.714M |
| December 31, 2025 | 0.90M |
| September 30, 2025 | 0.877M |
| June 30, 2025 | 0.80M |
| March 31, 2025 | 1.067M |
| December 31, 2024 | 0.725M |
| September 30, 2024 | 0.70M |
| June 30, 2024 | 1.282M |
| March 31, 2024 | 1.441M |
| December 31, 2023 | 2.086M |
| September 30, 2023 | 2.341M |
| June 30, 2023 | 4.947M |
| March 31, 2023 | 7.531M |
| December 31, 2022 | 7.627M |
| September 30, 2022 | 8.529M |
| June 30, 2022 | 9.852M |
| March 31, 2022 | 9.491M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.08M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 10.51M |
| March 31, 2021 | 51.53M |
| December 31, 2020 | 55.88M |
| September 30, 2020 | 56.05M |
| June 30, 2020 | 61.94M |
| March 31, 2020 | 58.49M |
| December 31, 2019 | 88.75M |
| September 30, 2019 | 90.51M |
| June 30, 2019 | 94.31M |
| March 31, 2019 | 17.52M |
| December 31, 2018 | 17.85M |
| September 30, 2018 | 14.88M |
| June 30, 2018 | 14.33M |
| March 31, 2018 | |
| December 31, 2017 | 14.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Climb Bio, Inc. | 6.747M |
| Q32 Bio, Inc. | 9.962M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.93M |
| Shareholders Equity (Quarterly) | 5.087M |
| Current Ratio | 0.8215 |